Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03822351
Title Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC (COAST)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedImmune LLC
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN

No variant requirements are available.